Step into the realm of DASI Simulations’ press stories, where innovation meets excellence in the dynamic landscape of healthcare technology. These narratives capture the essence of our journey, showcasing how our predictive modeling and artificial intelligence solutions are revolutionizing cardiac care. From prestigious awards and featured events to grants that fuel our cutting-edge initiatives, these press stories unveil the pivotal moments that define DASI’s trajectory. Immerse yourself in a tapestry of recognition, collaboration, and technological prowess as we navigate the forefront of cardiac healthcare, making waves and garnering acclaim in the process. Explore the unfolding chapters that highlight our commitment to reshaping the future of cardiovascular interventions.
Accelerating Angels, an angel investment fund and network giving women-owned startup companies the capital they need to scale their businesses, has selected the recipient of its third investment - DASI SImulations
DASI Simulations featured in CityScene Magazine for healthcare innovation stemming from Dublin, Ohio.
DASI Simulations featured in CityScene Magazine for healthcare innovation stemming from Dublin, Ohio.
DASI Simulations, a leading innovator in AI-driven healthcare technologies, proudly announces its inclusion in the esteemed shortlist for the inaugural Global Cardiovascular Awards.
DASI Simulations as CMS grants approval for a $1000 reimbursement per report for PrecisionTAVI, marking a pivotal moment for the FDA-cleared predictive modeling product designed for transcatheter aortic valve replacement (TAVR).
DASI Simulations, a startup founded in 2020 by Georgia Tech professor Dr. Lakshmi Dasi and Teri Sirset, aims to address this issue with predictive artificial intelligence (AI) that enables personalized and optimized treatment.
AI for Preprocedural TAVR Modeling Gains FDA Clearance Diagnostic & Interventional Cardiology -- June 9, 2023 – Dasi Simulations announced it received FDA clearance for its artificial intelligence model for preprocedure transcatheter aortic…
DASI Simulation’s Precision TAVI earns FDA Clearance Precision TAVI is the first FDA approved predictive modeling tool for medical teams planning TAVR proceduresCath Lab Digest -- Dublin, OH -- June…
US FDA approval for AI TAVI planning software CardiovascularNews -- June 8, 2023 – DASI Simulations has announced it has received US Food and Drug Administration (FDA) clearance for its artificial…
AI for preprocedural TAVR modeling gains FDA clearance Healio -- June 7, 2023 – Dasi Simulations announced it received FDA clearance for its artificial intelligence model for preprocedure transcatheter aortic…